D'Orazio & Associates, Inc. Innoviva, Inc. Transaction History

D'Orazio & Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$15.91 - $18.72 $1,113 - $1,310	-70 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$13.06 - $17.24 $914 - $1,206	70 New	70 $1,000
Q2 2019 Aug 05, 2019	SELL	$13.1 - $14.95 $6,550 - $7,475	-500 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$13.69 - $20.06 $6,845 - $10,030	500 New	500 $7,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.32B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on D'Orazio & Associates, Inc. with notifications on news.